Research and Development

Diabetes is one of the most common non-communicable diseases worldwide and is an escalating public health problem globally, with an …

The US FDA has approved Baxalta’s twice-weekly therapy Adynovate for use in adults and adolescents, aged 12 years plus, with …

Novo Nordisk has unveiled plans to combat urban diabetes in a $20 million investment offering expert resources and research funds …

Amgen says its Humira (adalimumab) biosimilar candidate ABP 501 proved its clinical equivalence to Abbvie’s blockbuster drug in a head-to-head …

Dr Mene Pangalos, executive vice president of the IMED Biotech Unit at AstraZeneca UK, has accepted two prestigious appointments that …

The American Heart Association and Google Life Sciences have announced a joint research collaboration to bring ‘unconventional thinking’ to the …

Boehringer Ingelheim has launched its new research and development strategy, committing €11 billion to R&D over the next five years. …

Pharma’s new-found willingness to embrace all aspects of the digital age, and use it both to its advantage and that …

Having presented positive late-stage results for a new formulation of its inflammatory drug Benlysta, GSK says it will file supplementary …

Astellas Pharma has agreed to buy Ocata, a firm specialising in cloning and embryonic stem cell therapies, for $379 million. …

The FDA has approved the skin cancer drug Cotellic for certain forms of melanoma in combination with another Roche cancer …

A shortage of skilled professionals threatens to undermine research and development of new medicines in the UK and prevent growth …

A Novo Nordisk-sponsored study of the cost-effectiveness of three different injectable anti-diabetes drugs has found Victoza is a cheaper option …

Eli Lilly says its investigational therapy baricitinib outperformed AbbVie’s Humira after 12 weeks in a late-stage study of people with …

The UK pharma trade body, the ABPI, has welcomed the findings of the Science and Technology Committee’s inquiry into the …